Molecule Details
| InChIKey | HLJCVRXGZMOFDS-UHFFFAOYSA-N |
|---|---|
| Compound Name | 2,6-dichloro-N-(difluoromethyl)-4-(3-(1-methylpiperidin-4-yl)propyl)-N-(1,3,5-trimethyl-1H-pyrazol-4-yl)benzenesulfonamide |
| Canonical SMILES | Cc1nn(C)c(C)c1N(C(F)F)S(=O)(=O)c1c(Cl)cc(CCCC2CCN(C)CC2)cc1Cl |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 4 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 8.02 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
Target Activities (4)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P30419 | NMT1 | Homo sapiens | Human | PF01233 PF02799 | 7.9 | IC50 | ChEMBL;BindingDB |
| Q12809 | KCNH2 | Homo sapiens | Human | PF00027 PF00520 PF13426 | 6.2 | IC50 | ChEMBL;BindingDB |
| Q4Q5S8 | NMT | Leishmania major | Pathogen | PF01233 PF02799 | 9.2 | IC50 | ChEMBL |
| Q388H8 | Trypanosoma brucei brucei (strain 927/4 GUTat10.1) | Pathogen | PF01233 PF02799 | 8.7 | IC50 | ChEMBL;BindingDB |